180 related articles for article (PubMed ID: 2878857)
1. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
[TBL] [Abstract][Full Text] [Related]
2. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
[No Abstract] [Full Text] [Related]
3. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
Juby LD; Burke DA; Axon AT
Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
[TBL] [Abstract][Full Text] [Related]
5. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
Clements D; Elias E
Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
[No Abstract] [Full Text] [Related]
6. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin and analogues in the treatment of VIPoma.
O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
[No Abstract] [Full Text] [Related]
8. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
[TBL] [Abstract][Full Text] [Related]
9. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
10. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
Santangelo WC; Dueno MI; Krejs GJ
Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
[No Abstract] [Full Text] [Related]
11. Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes.
Vinik AI; Tsai ST; Moattari AR; Cheung P; Eckhauser FE; Cho K
Am J Med; 1986 Dec; 81(6B):23-40. PubMed ID: 2879447
[TBL] [Abstract][Full Text] [Related]
12. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
Christensen C
Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
[TBL] [Abstract][Full Text] [Related]
13. Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours.
Lamberts SW; Pieters GF; Metselaar HJ; Ong GL; Tan HS; Reubi JC
Acta Endocrinol (Copenh); 1988 Dec; 119(4):561-6. PubMed ID: 2849276
[TBL] [Abstract][Full Text] [Related]
14. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
Maton PN; Gardner JD; Jensen RT
Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogs in the management of gastrointestinal tumors.
Lamberts SW
Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
[TBL] [Abstract][Full Text] [Related]
17. [Short-term treatment of a VIPoma with somatostatin analogue in advance of curative operation].
Yoshioka M; Sakazume M; Fukagawa M; Seki T
Nihon Naika Gakkai Zasshi; 1988 Aug; 77(8):1276-7. PubMed ID: 2853716
[No Abstract] [Full Text] [Related]
18. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
Maton PN; O'Dorisio TM; Howe BA; McArthur KE; Howard JM; Cherner JA; Malarkey TB; Collen MJ; Gardner JD; Jensen RT
N Engl J Med; 1985 Jan; 312(1):17-21. PubMed ID: 2856888
[No Abstract] [Full Text] [Related]
19. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]